| Dr Mhroos Faik Barak Peters, MD | |
|
16000 Johnston Memorial Dr Fl 4, Abingdon, VA 24211-7664 | |
| (276) 258-1000 | |
| Not Available |
| Full Name | Dr Mhroos Faik Barak Peters |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 27 Years |
| Location | 16000 Johnston Memorial Dr Fl 4, Abingdon, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083734123 | NPI | - | NPPES |
| 03037390 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 249349 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Russell County Hospital | Lebanon, VA | Hospital |
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blue Ridge Medical Management Corporation | 9739099441 | 308 |
News Archive
Non-alcoholic fatty liver diseases (NAFLD) and alcohol-related diseases (ALD) are currently the leading cause of chronic disease, cancer and mortality associated with this organ in developed countries.
A study of cochlear implant patients seen by Indiana University School of Medicine physicians is the first research to show evidence that cochlear implants in both ears significantly improves quality of life in patients with profound hearing loss and that the cost of the second implant is offset by its benefits.
W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.
Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate - a class of drugs that prevent loss of bone mass.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.
› Verified 5 days ago
| Entity Name | Blue Ridge Medical Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326159567 PECOS PAC ID: 9739099441 Enrollment ID: O20040715001336 |
News Archive
Non-alcoholic fatty liver diseases (NAFLD) and alcohol-related diseases (ALD) are currently the leading cause of chronic disease, cancer and mortality associated with this organ in developed countries.
A study of cochlear implant patients seen by Indiana University School of Medicine physicians is the first research to show evidence that cochlear implants in both ears significantly improves quality of life in patients with profound hearing loss and that the cost of the second implant is offset by its benefits.
W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.
Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate - a class of drugs that prevent loss of bone mass.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.
› Verified 5 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174808216 PECOS PAC ID: 8123291739 Enrollment ID: O20120627000467 |
News Archive
Non-alcoholic fatty liver diseases (NAFLD) and alcohol-related diseases (ALD) are currently the leading cause of chronic disease, cancer and mortality associated with this organ in developed countries.
A study of cochlear implant patients seen by Indiana University School of Medicine physicians is the first research to show evidence that cochlear implants in both ears significantly improves quality of life in patients with profound hearing loss and that the cost of the second implant is offset by its benefits.
W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.
Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate - a class of drugs that prevent loss of bone mass.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mhroos Faik Barak Peters, MD 1021 W Oakland Ave Ste 310, Johnson City, TN 37604-2192 Ph: (423) 302-6565 | Dr Mhroos Faik Barak Peters, MD 16000 Johnston Memorial Dr Fl 4, Abingdon, VA 24211-7664 Ph: (276) 258-1000 |
News Archive
Non-alcoholic fatty liver diseases (NAFLD) and alcohol-related diseases (ALD) are currently the leading cause of chronic disease, cancer and mortality associated with this organ in developed countries.
A study of cochlear implant patients seen by Indiana University School of Medicine physicians is the first research to show evidence that cochlear implants in both ears significantly improves quality of life in patients with profound hearing loss and that the cost of the second implant is offset by its benefits.
W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.
Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate - a class of drugs that prevent loss of bone mass.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.
› Verified 5 days ago
Dr. Joe Rupe, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-4050 Fax: 276-258-4056 | |
Dr. Beverly Tara Smith, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-1000 | |
Maung M. Kyi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 312c, Abingdon, VA 24211 Phone: 276-258-1985 Fax: 276-258-1989 | |
Dr. Andrew Waller, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 300 Valley St Ne, Abingdon, VA 24210 Phone: 276-206-8197 Fax: 276-206-8761 | |
Martin Monahan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 322 E Valley St, Abingdon, VA 24210 Phone: 276-628-1106 Fax: 276-676-0215 | |
Dr. Gregory H Miller, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 212a, Abingdon, VA 24211 Phone: 276-258-3740 Fax: 276-258-3745 | |
John Byron Patterson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 212a, Abingdon, VA 24211 Phone: 276-258-3740 Fax: 276-258-3745 |